Program
Monday, August 20th
| Time | Event | Location |
|---|---|---|
| 6:00-7:30pm | Opening Session | Grand Ballroom |
| 6:00-6:05pm |
Welcome remarks and introduction Lawrence Corey University of Washington and Fred Hutchinson Cancer Research Center |
|
| 6:05-6:10pm |
Message from Christine Gregoire Governor of Washington |
|
| 6:10-6:20pm |
Welcome to Seattle Patricia McInturff Director, Seattle Department of Human Services |
|
| 6:20-6:50pm |
Responding to the AIDS Pandemic Tachi Yamada Director, Global Health Program Bill and Melinda Gates Foundation |
|
| 6:50-7:10pm |
AIDS Vaccine 2007: Much Accomplished, Much to do Anthony S. Fauci Director, National Institutes of Allergy and Infectious Diseases |
|
| 7:10pm-7:30 |
Finding a Path to Development of an HIV Vaccine Barton Haynes Duke University Medical Center |
|
| 7:30-9:30pm | Poster Session #1 and Welcome Reception | Metropolitan Ballroom |
| 8:00-9:00pm | Poster Discussion #1: Social, Ethical, and Regulatory Issues in Clinical Trials Implementation Gabrielle Lamourelle Butch McKay Kimberly Louis Kevin Fisher Chawetson Namwat Zuhayr Kafaar |
Metropolitan Ballroom |
Tuesday, August 21st
| Time | Event | Location |
|---|---|---|
| 7:00-8:30am | Breakfast Buffet and Coffee Service | Grand Ballroom Foyer and Willow Ballroom |
| 8:30-10:00am | Plenary #1 Julie McElrath, Chair David Baker - Computational design of novel immunogens Robin Weiss - The nature of protective antibodies Mark Feinberg - From test of concept to global access: needs and questions moving forward |
Grand Ballroom |
| 10:00-10:30am | Break - Food and Beverages Available | |
| 10:30am-12:30pm | Oral Abstract Session #1 Vaccine Concepts and Design Part 1 Chairs: Carolyn Williamson and Saladin Osmanov Pengfei Jiang Heather Desaire Patrice DebreY. Liu Lance Ching Robert LuallenSusan Zolla-Pazner Xunqing Jiang |
Grand Ballroom B |
| 10:30am-12:30pm | Oral Abstract Session #2 Clinical trials Part 1 Chairs: Nelson Michael and Yves Levy Sandhya Vasan Michael KeeferEric Sandstrom Paul Goepfert Deborah PersaudJohannes Hain Eftyhia Vardas |
Grand Ballroom C |
| 10:30am-12:30pm | Oral Abstract Session #3 T Cell and Mucosal Immunity Chairs: Rafick Sekaly and Helen Horton Meritxell Genesca Ferrer David Kaufman Kimberly SchoenlyDennis Hartigan-O'Connor Uma Malhorta Sheri Dubey Bonnie ColletonSylvie Le Gall |
Grand Ballroom D |
| 12:30-1:30pm | Lunch Buffet | 2nd and 3rd floor Foyers |
| 1:30-3:00pm | Symposium #1 New Vectors and Adjuvants John Shiver, Chair Tom Dubensky - Harnessing (and controlling) L. monocytogenes to treat and prevent human disease Hussein Y Naim - Live attenuated measles virus vectorDan Barouch - Novel adenovirus vector-based vaccines for HIV-1 Anna-Lise Williamson - BCG as an HIV vaccine vector |
Grand Ballroom AB |
| 1:30-3:00pm | Symposium #2 Mucosal Immunity Bonnie Matheson, Chair David Koelle - Tissue-homing properties of human HSV-2-specific CD4 and CD8 T-cells Barbara L. Shacklett - Functional heterogeneity of HIV-specific T-cells in mucosal tissuesJo-Ann Shelley Passmore - Mucosal assessment of T cell magnitude and specificity during HIV infection: feasibility? Robin Shattock - Mucosal protection to HIV-1: what to induce and how to measure it |
Grand Ballroom C |
| 3:00-3:30pm | Break - Food and Beverages Available | |
| 3:30-5:00pm | Round Table #1 Innate Immunity and Adjuvants: Is it all TLR? Ken Rosenthal, Moderator David Nemazee Robert Seder Michael GaleHeather Davis |
Grand Ballroom AB |
| 3:30-5:00pm | Round Table #2 New Primate Models: Will they help HIV Vaccine Development? Nancy Haigwood, Moderator Martha MarthasJim Hoxie Norman Letvin Sal Butera |
Grand Ballroom C |
| 5:30-10:30pm | Dinner Excursion | Tillicum Village |
Wednesday, August 22nd
| Time | Event | Location |
|---|---|---|
| 7:00-8:30am | Breakfast Buffet and Coffee Service | Grand Ballroom Foyer and Willow Ballroom |
| 8:30-10:00am | Plenary #2 Pontiano Kaleebu, Chair Amalio Telenti - Human genome analysis - clues to vaccine development Otto Yang - CTL and the control of HIV-1 replication Glenda Gray - Future directions for HIV vaccine research in high HIV prevalence developing country settings |
Grand Ballroom |
| 10:00-10:30am | Break - Food and Beverages Available | |
| 10:30am-12:30pm | Oral Abstract Session #4 Vaccine Concepts and Design Part 2 Chairs: Wayne Koff and Steve Patterson Denis Gaucher Danilo Casimiro Frederic Martinon Lauren Hirao Jinyan Liu Petra Mooij David Clarke Shiu-Lok Hu |
Grand Ballroom B |
| 10:30am-12:30pm | Oral Abstract Session #5 B Cell Immunity Chairs: Lynn Morris and Dennis Burton S. Munir Alam Erin Scherer Christianne Moog Abraham Pinter Weimin Liu Catherine Blish Nancy HaigwoodBruce Brown |
Grand Ballroom C |
| 10:30am-12:30pm | Oral Abstract Session #6 Animal Models Chairs: Louis Picker and Marta Marthas James Binley Kenneth Chan Jodi Craigo David EvansCristian Apetrei Rama Rao Amara Guido SilvestriJean Boyer |
Grand Ballroom D |
| 12:30-1:30pm | Lunch Buffet | 2nd and 3rd floor Foyers |
| 1:30-3:30pm | Symposium #3 Clinical Trials Susan Buchbinder, chair Michael Robertson - Update on the Merck Ad5 phase II trial (the STEP study--Merck V520 protocol 023/HVTN 502) Supachai Perks-Ngarm - Challenges in conducting large community-based trials in Asia Helen Horton - Mapping HIV-1 T cell epitopes in humans participating in clinical trials of candidate HIV-1 vaccinesSteve DeRosa - Comparison of vaccine responses using pox vs ad vectors: the HVTN experience Scott Hammer - HIV vaccine efficacy trials in a changing environment: potential effects of male circumcision, PrEP, and microbicidesRichard Koup - Update on safety and immunogenicity of VRC products |
Grand Ballroom AB |
| 1:30-3:30pm | Round Table #3 Defining the Specificities in Broadly Neutralizing Sera Leo Stamatatos, moderator John Mascola Dennis Burton George Shaw James Binley Alexandra TrkolaLynn Morris Susan Zola Panzer |
Grand Ballroom C |
| 3:30-4:00pm | Break - Food and Beverages Available | |
| 4:00-6:00pm | Symposium #4 Host Immunity and the Control of Viral Infection Giuseppe Pantaleo, Chair Marcus Altfeld - Innate immunity in HIV-1 infection Louis Picker - Central vs. effectors memory T cells Rafick-Pierre Sekaly - Survival mechanisms of memory T cells: implications for vaccine development Raymond Welsh - Pathogenic epitomes, heterogonous immunity, and vaccine design |
Grand Ballroom AB |
| 4:00-6:00pm | Symposium #5 Therapeutic Vaccines Brigitte Autran, Chair Nina Bhardwaj - Targeting dendritic cells for immunotherapeutic purposes Pierre Alexandre Bart - Is there a future for therapeutic vaccines? George Pavlakis - Benefit of DNA therapeutic vaccination in macaques Mary Marovich - Dendritic cell vaccination with HIV antigens in humans |
Grand Ballroom C |
| 6:00-8:00pm | Poster Session #2 Wine and Cheese Reception |
Metropolitan Ballroom |
| 6:30-7:00pm | Poster Discussion #2 Clinical Trial Site Development Lu Yin Eftyhia Vardas Suchada Chinaworapong |
Metropolitan Ballroom |
Thursday, August 23rd
| Time | Event | Location |
|---|---|---|
| 7:00-8:30am | Breakfast Buffet and Coffee Service | Grand Ballroom Foyer and Willow Ballroom |
| 8:30-10:00am | Symposium #6 Neutralization and B-Cell Response David Ho, Chair Barton Haynes - Antibody polyspecificity and neutralization of HIV Christiane Moog - Inhibitory activity of antibodies evaluated on different type of primary target cells Bing Chen - A broadly neutralizing antibody recognizes a fusion-intermediate state of HIV-1 gp41Dennis Burton |
Grand Ballroom AB |
| 8:30-10:00am | Symposium #7 Improving Immunogen Design Steve Self, Chair Francine McCutchan - Defining the global epidemiology of HIV Fusheng Li - Heterologous insert prime-boost vaccination has the potential to overcome HIV-1 antigen diversity Ralph Wagner - Impact of RNA- and codon-optimization on safety, immunogenicity and efficacy of HIV candidate vaccines Bette Korber - Characteristics of HIV at acute infection |
Grand Ballroom C |
| 10:00-10:30am | Break - Food and Beverages Available | |
| 10:30am-12:30pm | Oral Abstract Session #7 Acute HIV/HIV Transmission Chairs: George Shaw and Julie Overbaugh Thomas Hope Brandon Keele Terri Wrin Tanawan Samleerat Penny Moore Bhavna Chohan Eric HunterTuofu Zhu |
Grand Ballroom B |
| 10:30am-12:30pm | Oral Abstract Session #8 Clinical Trials Part 2 Chairs: Steve Kent and John Hural Cecilia Morgan Scott Hammer Walter Jaoko Michael Keefer Clayton Harro Ray Dolin |
Grand Ballroom C |
| 10:30am-12:30pm | Oral Abstract Session #9 Immune Escape Chairs: Steve DeRosa and Mario Roederer Todd Allen Zabrina Brumme Viv Peut Julia Richardt Paul Goepfert Arne Scheidewind Ralph Pantophlet Julian Blanco |
Grand Ballroom D |
| 12:30-1:30pm | Lunch Buffet | 2nd and 3rd floor Foyers |
| 1:30-2:45pm |
Plenary #3 Peggy Johnston and Jose Esparza, Co-Chairs Jose Esparza - The enterprise, progress and challenges David Montefiori - Emerging issues in humoral response to HIV Robin Shattock - Emerging issues in mucosal and innate immunity to HIV Nina Russell - Innovative clinical trial designs to expedite vaccine efficacy evaluation Bill Snow - The as-yet unrealized potential of the enterprise |
Grand Ballroom |
| 2:45-3:45pm | Rapporteurs | Grand Ballroom |
| 3:45-4:15pm | Break - Food and Beverages Available | |
| 4:15-5:45pm |
Late Breaker Oral Abstracts Dimiter Dimitrov Sampa Santra Robert Palermo Nicholas Steers Andrei Kozlov Mina John Marta Marthas |
Grand Ballroom |
| 5:45-6:00pm | Handover | Grand Ballroom |